Home/Filings/4/0001474506-25-000100
4//SEC Filing

Kim Christopher 4

Accession 0001474506-25-000100

CIK 0001894525other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 5:00 PM ET

Size

4.6 KB

Accession

0001474506-25-000100

Insider Transaction Report

Form 4
Period: 2025-05-16
Kim Christopher
DirectorChairman and CMO
Transactions
  • Award

    Common Stock, par value $0.01 per share

    2025-05-16+250,000277,500 total

Issuer

Apimeds Pharmaceuticals US, Inc.

CIK 0001894525

Entity typeother

Related Parties

1
  • filerCIK 0002040022

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:00 PM ET
Size
4.6 KB